BioCentury | Aug 9, 2012
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...information Endocrine/metabolic disease Endocrine disease Pyroglutamylated RFamide peptide receptor (QRFPR; GPR103) Mouse and in vitro studies suggest a GPR103...
...anorexia. Chemical synthesis and in vitro testing identified a lead peptidomimetic that had more potent GPR103...
Items per page:
1 - 1 of 1